Established in September 2020, Shanghai ConFlow MedTech Co., Ltd., known as "ConFlow MedTech," stands as a distinguished high-tech company dedicated to research and development, manufacturing, and industrialization of innovative cardiovascular medical devices. Through continuous independent research and development and clinical application of cutting-edge technologies, we are committed to becoming a world-class innovative product manufacturer with international influence.

Nestled in the heart of Songjiang Science and Technology City, Shanghai Lingang Group, our headquarters occupies a spacious 2,200-square-meter complex. This facility boasts a pristine environment featuring a 10k-Grade clean workshop, well-equipped laboratories, machining platforms, and modern office spaces. Furthermore, it features state-of-the-art hardware facilities that play a pivotal role in bolstering the company's R&D endeavors, as well as expediting project progress.

ConFlow MedTech has gained strong support and praise from government bodies and institutional investors since its inception. We've secured significant funding of nearly RMB100 million from esteemed institutions like TigerYeah Capital, Taikun Fund, and Yuanlai Yuanqi Venture Capital. Furthermore, our company has earned recognition through various certifications, including those for innovation-oriented SMEs, science and technology-based enterprises, and specialized and sophisticated SMEs in Shanghai. The company's medical-engineering transformation and innovative research and development business are thriving.

Diving into the realm of medical-engineering transformation and pioneering research and development, the company has achieved remarkable growth. Its product portfolio now encompasses a wide spectrum of offerings, spanning heart failure treatment, interventional therapy for congenital heart disease, valve products, and peripheral vascular therapy devices.